Clinicopathologic Features Associated with Long-Term Survival in Node-Negative Breast Cancer Patients

Surgery Today

Volumn 26, Issue 2, 1996, Pages 105-114

  Kato, Takao ^a   Kimura, Tsunehito ^a   Miyakawa, Ryuhei ^a   Tanaka, Shinichi ^a   Kamio, Takako ^a   Yamamoto, Kazuko ^a   Hamano, Kyoichi ^a   Aiba, Motohiko ^a   Kawakami, Makio ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Blood vessel invasion; Clinical tumor size; Node negative breast cancer

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; PROGNOSIS; SURVIVAL TIME;

ADULT; AGED; BREAST; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY, EXTENDED RADICAL; MASTECTOMY, MODIFIED RADICAL; MASTECTOMY, RADICAL; MIDDLE AGED; MITOTIC INDEX; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0029913110     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00311773     Document Type: Article

References (29)

1. Fisher B, Redmond C, Dimitrov NV, Bowman D, Legault-Poisson S, Wickerham DL, Wolmark N, Fisher ER, Margolese R, Sutherland C, Glass A, Foster R, Caplan R (1989) A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med 320:473-478
2. Fisher B, Constantino J, Redmond C, Poisson R, Bowman D, Couture J, Dimitrov NV, Wolmark N, Wickeham DL, Fisher ER, Margolese R, Robidoux A, Shibata H, Terz J, Paterson AHG, Feldman M, Farrar W, Evans J, Lickley HL, Ketner M (1989) A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320:479-484
3. Mansour EG, Gray R, Shatila AH, Osborne CK, Tormey DC, Gilchrist KW, Cooper MR, Falkson G (1989) Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. N Engl J Med 320:485-490
4. Weigand RA, Isenberg WM, Russo J, Brennan MJ, Rich MA (1982) The breast cancer prognostic study associates: Blood vessel invasion and axillary lymph node involvement as prognostic indicators for human breast cancer. Cancer 50:962-969
5. Van de Velde CJH, Gallager HS, Giacco GG (1986) Prognosis in node-negative breast cancer. Breast Cancer Res Treat 8:189-196
6. Fracchia AA, Rosen PP, Ashikari R (1980) Primary carcinoma of the breast without axillary lymph node metastases. Surg Gynecol Obstet 151:375-378
7. Sears HF, Janus C, Levy W, Hopson R, Creech R, Grotzinger P (1982) Breast cancer without axillary metastases. Are there high-risk biologic subpopulations? Cancer 50:1820-1827
8. Bilik R, Mor C, Wolloch Y, Dintsman M (1986) Histopathologic high risk factors influencing the prognosis of patients with early breast cancer (T1N0M0). Am J Surg 151:460-464
9. Bloom HIJ, Richardson WW (1957) Histologic grading and prognosis. Br J Cancer 11:359-377
10. Black MM, Speer FD, Opler SR (1956) Structural representations of tumor-host relationships in mammary carcinoma. Biologic and prognostic significance. Am J Cinic Pathol 26:250-265
11. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
12. Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170
13. Sampat MB, Sirsat MV, Gangadharan P (1978) Prognostic significance of blood vessel invasion in carcinoma of the breast in women. J Surg Oncol 9:623-632
14. Burgdorf WHC, Mukai K, Rosai J (1981) Immunohistochemical identification of factor VIII-related antigen in endothelial cells of cutaneous lesions of alleged vascular nature. Am J Clin Pathol 75:167-171
15. Bettelheim R, Mitchell D, Gusterson BA (1984) Immunocytochemistry in the identification of vascular invasion in breast cancer. J Clin Pathol 37:364-366
16. Martin SA, Perez-Reyes N, Mendelsohn G (1987) Angioinvasion in breast carcinoma. An immunohistochemical study of factor VIII-related antigen. Cancer 59:1918-1922
17. Saigo PE, Rosen PP (1987) The application of immunohistochemical stains to identify endothelial-lined channels in mammary carcinoma. Cancer 59:51-54
18. Kato T, Kimura T, Muraki H, Kamio T, Fujii A, Yamamoto K, Hamano K, Aiba M, Kawakami M (1993) Studies on pathological factors and blood vessel invasion by using immunoperoxidase technique for factor VIII-related antigen in breast cancer (third report): Use of elastica van Gieson staining. (in Japanese with English abstract). Nippon Rinsho Geka Igakkai Zasshi (J Jpn Soc Clin Surg) 54:294-301
19. Tsugita M, Suzuki H, Suzuki S, Fukushima Y, Kitamura Y, Suguro M, Ohta S, Araida M, Ankoh H, Kobayashi S, Hanyu F (1988) Detection of vascular invasion on the operative specimen of gastric cancers (in Japanese with English abstract). Nippon Gan Chiryou Gakkai Zasshi (J Jpn Soc Cancer Ther) 23:688-695
20. Fisher B, Slack NH, Bross IDJ, cooperating investigators (1969) Cancer of the breast: size of neoplasm and prognosis. Cancer 24:1071-1080
21. Rosen PP, Groshen S, Saigo PE, Kinne DW, Hellman S (1989) A long-term follow-up study of survival in Stage I (T1N0M0) and Stage II (T1N1M0) breast carcinoma. J Clin Oncol 7: 355-366
22. Clayton F (1991) Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor. Cancer 68:1309-1317
23. Valagussa P, Bonadonna G, Veronesi U (1978) Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer 41:1170-1178
24. Lee AKC, Delellis RA, Silverman ML, Heatley GJ, Wolfe HJ (1990) Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast. J Clin Oncol 8:1457-1465
25. Clemente CG, Boracchi P, Andreola S, Del Vecchio M, Veronesei P, Rilke FO (1992) Peritumoral lymphatic invasion in patients with node-negative mammary duct carcinoma. Cancer 69:1396-1403
26. Davis BW, Gelber RD, Goldhirsch A, Hartmann WH, Locher GW, Reed R, Golouh R, Save-Soderbergh, Holloway L, Russel I, Rudenstam M (1986) Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Cancer 58:2662-2670
27. Elston CW (1984) The assessment of histological differentiation in breast cancer. Aust NZ J Surg 54:11-15
28. Rank F, Dombernowsky P, Jespersen NCB, Pedersen BV, Keiding N (1987) Histologic malignancy grading of invasive ductal breast carcinoma. Cancer 60:1299-1305
29. Carter D, Elkins RC, Pipkin RD, Abbey H, Shepard RH (1978) Relationship of necrosis and tumor border to lymph node metastasis and 10-year survival in carcinoma of the breast. Am J Surg Pathol 2:39-46